Leave a Message
We will call you back soon!
Your message must be between 20-3,000 characters!
Please check your E-mail!
SUBMIT
|
Sermaglutide CAS 910463-68-2 Molecular Weight 4113.64
On September 20, 2019, the FDA officially approved the marketing application for Sommarutide, which is used in combination with diet and exercise to improve blood sugar control in patients with type 2 diabetes.
Sommarutide is a human GLP-1 analogue with high albumin affinity and a long half-life. It can be administered once a week to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner.
Storage method: freeze drying at -20℃ and storage away from light.
|
|
Sermaglutide CAS 910463-68-2 Molecular Weight 4113.64
On September 20, 2019, the FDA officially approved the marketing application for Sommarutide, which is used in combination with diet and exercise to improve blood sugar control in patients with type 2 diabetes.
Sommarutide is a human GLP-1 analogue with high albumin affinity and a long half-life. It can be administered once a week to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner.
Storage method: freeze drying at -20℃ and storage away from light.